MULTI-MODAL PAIN TREATMENT FOR CANCER PAIN REDUCES POTENTIAL HARM OF LONG-TERM OPIOID USE
VALENCIA, 4 September 2019 – Multi-modal pain treatment for cancer patients, as well as continuous assessment and understanding the risk factors for opioid misuse, will reduce the potential harm of opioids in cancer care, delegates at the European Pain Federation’s...
Press release: unlocking the secrets of how genetic variation affects perception of pain could lead to personalised medicines
VALENCIA, 4 September 2019 – Gene studies reveal that about half of our sensitivity to pain is determined by our genetic makeup, with key differences caused by variant forms of individual genes, delegates at the European Pain Federation’s biennial Congress in...
WOMEN ‘THREE TIMES MORE PRONE TO MIGRAINE’ THAN MEN
VALENCIA, 3 September 2019 – Migraines affect around 15% of the general population (around 1.2bn people globally) and the disorder is three times more prevalent in women than in men, delegates at the European Pain Federation’s biennial Congress in Valencia, Spain,...
PRESS RELEASE: OBJECTIVE PAIN MEASURMENT COULD BE A ‘GAME-CHANGER’ FOR PATIENTS
BRUSSELS, 2 September 2019 – New research into objective measurement of pain could be a ‘game-changer’ for patients, delegates at the European Pain Federation’s biennial Congress in Valencia, Spain, will be told. Until now, a patient’s experience of pain has always...